{"transactions":[{"id":752345,"issuer":{"id":5539,"kind":"organization","name":"Evommune, Inc."},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-04T00:04:23.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":15673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option award shall vest at the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15673,"derivative":{"exercise_price":19.82,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":15673},"source":{"system":"sec-edgar","filing":"0001216994-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044725/000121699426000003/primarydocument.xml","form_type":"4"}},{"id":1005020,"issuer":{"id":5539,"kind":"organization","name":"Evommune, Inc."},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-07T21:15:15.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":37960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":37960,"derivative":{"exercise_price":16,"expiration_date":"2035-11-04","underlying":"Common Stock","underlying_shares":37960},"source":{"system":"sec-edgar","filing":"0001216994-25-000008","document":"form4-11072025_041110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044725/000121699425000008/form4-11072025_041110.xml","form_type":"4"}},{"id":2108332,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:57:44.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":16854,"price":9.14,"value":154045.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.11,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":16854},"source":{"system":"sec-edgar","filing":"0001209191-22-058189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122058189/doc4.xml","form_type":"4"}},{"id":2108331,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:57:44.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":102412,"price":3.66,"value":374827.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":102412},"source":{"system":"sec-edgar","filing":"0001209191-22-058189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122058189/doc4.xml","form_type":"4"}},{"id":2108330,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:57:44.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":1.98,"value":15444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.27,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-22-058189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122058189/doc4.xml","form_type":"4"}},{"id":2108329,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T21:57:44.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":41984,"price":15.25,"value":640256.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each of the reported shares of common stock of the Company (each a \"Share\" or, collectively, the \"Shares\"), including any Shares of restricted stock, was, at the Effective Time (defined below), cancelled and converted into the right to receive $15.25 in cash (the \"Merger Consideration\") without interest and subject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-058189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122058189/doc4.xml","form_type":"4"}},{"id":2233840,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T21:18:34.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is\nscheduled to vest ratably on each of the first 12 monthly anniversaries of June 9, 2022."}],"balance_after":16854,"derivative":{"exercise_price":6.11,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":16854},"source":{"system":"sec-edgar","filing":"0001209191-22-036397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122036397/doc4.xml","form_type":"4"}},{"id":2233839,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:18:34.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common\nStock are scheduled to vest on June 9, 2023."}],"balance_after":41984,"source":{"system":"sec-edgar","filing":"0001209191-22-036397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122036397/doc4.xml","form_type":"4"}},{"id":2359944,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Common Stock","published_at":"2022-03-02T22:38:42.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":10324,"price":8.3,"value":85689.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock."}],"balance_after":35739,"source":{"system":"sec-edgar","filing":"0001209191-22-014974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919122014974/doc4.xml","form_type":"4"}},{"id":2561788,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-22T21:40:10.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":102412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, this option is scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO."}],"balance_after":102412,"derivative":{"exercise_price":11.59,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":102412},"source":{"system":"sec-edgar","filing":"0001209191-21-057288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919121057288/doc4.xml","form_type":"4"}},{"id":2561787,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Common Stock","published_at":"2021-09-22T21:40:10.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":34513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, these shares of Common Stock are scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO."}],"balance_after":46063,"source":{"system":"sec-edgar","filing":"0001209191-21-057288","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919121057288/doc4.xml","form_type":"4"}},{"id":2660450,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T20:36:26.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 17, 2021."}],"balance_after":7800,"derivative":{"exercise_price":16.21,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-21-042031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919121042031/doc4.xml","form_type":"4"}},{"id":2660449,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:36:26.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 17, 2022."}],"balance_after":11550,"source":{"system":"sec-edgar","filing":"0001209191-21-042031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919121042031/doc4.xml","form_type":"4"}},{"id":3097438,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-30T00:02:22.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 11, 2020."}],"balance_after":7800,"derivative":{"exercise_price":13.27,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-20-039260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919120039260/doc4.xml","form_type":"4"}},{"id":3097437,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T00:02:22.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 11, 2021."}],"balance_after":9800,"source":{"system":"sec-edgar","filing":"0001209191-20-039260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919120039260/doc4.xml","form_type":"4"}},{"id":3513136,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T22:14:57.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019."}],"balance_after":7800,"derivative":{"exercise_price":39.44,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-19-032435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919119032435/doc4.xml","form_type":"4"}},{"id":3513135,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-23T22:14:57.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020."}],"balance_after":8050,"source":{"system":"sec-edgar","filing":"0001209191-19-032435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919119032435/doc4.xml","form_type":"4"}},{"id":3899697,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-09T00:07:38.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 7, 2018."}],"balance_after":7800,"derivative":{"exercise_price":65.15,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-18-036813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919118036813/doc4.xml","form_type":"4"}},{"id":3899696,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-09T00:07:38.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 7, 2019."}],"balance_after":6300,"source":{"system":"sec-edgar","filing":"0001209191-18-036813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919118036813/doc4.xml","form_type":"4"}},{"id":4286790,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T20:07:02.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 8, 2017."}],"balance_after":10000,"derivative":{"exercise_price":52.85,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-038857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919117038857/doc4.xml","form_type":"4"}},{"id":4286789,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":41843,"kind":"person","name":"MCGRAW BENJAMIN F III","position":1,"cik":"0001216994","reported_name":"MCGRAW BENJAMIN F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T20:07:02.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 8, 2018."}],"balance_after":4550,"source":{"system":"sec-edgar","filing":"0001209191-17-038857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216994/000120919117038857/doc4.xml","form_type":"4"}}]}